How much does flurazepam cost?
The cost of flurazepam can vary depending on the dosage form, brand, and location. According to [1], the generic form of flurazepam is available in the United States, which can lead to lower prices compared to brand-name versions.
On average, a 1-month supply of generic flurazepam can cost between $4 to $15 for a 30-count bottle, depending on the pharmacy and insurance coverage [1]. However, prices may be higher for brand-name versions, such as Dalmane, which can range from $20 to $50 for the same dose and quantity [1].
It's essential to note that prices can fluctuate over time due to various factors, including changes in supply and demand, manufacturer pricing, and insurance coverage. Patients should check with their local pharmacies or healthcare providers for more accurate pricing information and potential discounts.
Who typically bears the cost of flurazepam?
Medicare Part D, a federal program that provides coverage for prescription medications, typically covers flurazepam but may have specific copayment requirements [2]. Additionally, many private insurance plans and Medicare Supplement Insurance (Medigap) plans also provide coverage for flurazepam, albeit with differing copayment and deductible requirements [2].
What are alternative options for patients seeking affordable flurazepam?
Patients facing financial difficulties may be eligible for patient assistance programs (PAPs) or non-profit discount programs, which can provide free or reduced-cost medications, including flurazepam [3]. However, the eligibility requirements and specifics of these programs may vary, and patients should consult their healthcare providers or a patient advocacy organization for guidance.
When does patent exclusivity expire for flurazepam?
According to [4], the U.S. Patent and Trademark Office (USPTO) has issued various patents related to flurazepam; however, it's difficult to pinpoint an exact date for the expiration of all patent exclusivities. Once patent exclusivities expire, it's likely that generic versions of flurazepam will become widely available, which may lead to lower prices and increased competition among manufacturers.
References:
1. DrugPatentWatch.com
2. Medicare.gov. (n.d.). Medicare Part D.
3. HealthWell Foundation. (n.d.). Help with Medication Costs.
4. USPTO.gov. (n.d.). Patent Search.